No Detail Found!

Prevalence and Risk Factors of Metabolic Syndrome in Women with Polycystic Ovarian Syndrome

Author(s)
Zahra Waseem Department of Obstetrics & Gynecology, CMH, Rawalpindi, Pakistan.
Tahira Riaz Department of Obstetrics & Gynecology, CMH, Rawalpindi, Pakistan.
Sadaf Shafique Department of Obstetrics & Gynecology, CMH, Rawalpindi, Pakistan.
Ghana Shahid Department of Obstetrics & Gynecology, CMH, Rawalpindi, Pakistan.
Islam Bano Department of Obstetrics & Gynecology, CMH, Rawalpindi, Pakistan.
Huma Shehzadi Department of Obstetrics & Gynecology, Pak Emirates Military Hospital, Rawalpindi, Pakistan.
Abstract
OBJECTIVE: To find out the prevalence and risk factors of metabolic syndrome among females presenting with polycystic ovarian syndrome (PCOS) in a tertiary care setting. METHODOLOGY: This cross-sectional study was performed at the Department of Obstetrics and Gynecology, Combined Military Hospital (CMH), Rawalpindi, Pakistan, from January to December 2022. A total of 277 non-pregnant females aged 18-35 years and diagnosed with PCOS presenting in the outpatient department were analyzed. Metabolic syndrome was diagnosed according to the AHA/NHLBI (ATP III) definition, while PCOS was labeled as per Rotterdam consensus guidelines. Prevalence of metabolic syndrome and associated risk factors were noted. RESULTS: In a total of 277 women with PCOS, the mean age was 27.4±5.6 years, while 149 (53.8%) women were aged between 18 and 25. The residential status of 189 (68.2%) women was rural. There were 81 (29.2%) women with PCOS who were found to have metabolic syndrome. Waist circumference = 80 cm (p=0.0031), HDL cholesterol 110 mg/dl (p<0.0001) were having significant association with the presence of metabolic syndrome. CONCLUSION: A high prevalence of metabolic syndrome was found among women with polycystic ovarian syndrome. Central obesity, hypertension and abnormal levels of FBG, triglyceride and highdensity lipoprotein were found to have a significant association with MBS among women with PCOS.
Publication Details
Page(s) 121-124
Published Journal: Journal of Liaquat University of Medical and Health Sciences, Volume: 23, Issue: 02, Year: 2024

Request the full text from PASTIC

Keywords
Obesity, Metabolic syndrome, Hypertension, Triglyceride, Polycystic ovarian syndrome
References
Witchel SF,Oberfield SE,Peña AS .2019 .Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc, 00078(8) : 1545-1573.
Deswal R,Narwal V,Dang A,Pundir CS .2020 .The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci, 95(4) : 18-271.
Christ JP,Cedars MI .2023 .Current Guidelines for Diagnosing PCOS. Diagnostics (Basel), 10(6) : 1113.
Rashmi B,Verma P,Gupta M. .2022 .Study of occurrence of risk factors of metabolic syndrome in women with PCOS. Indian J Obstet Gynecol Res, 068(3) : 357-360.
Ethirajulu A,Alkasabera A,Onyali CB,Comfort A,Shah HE,Bhawani N .2021 .Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome. Insulin Resistance, 10(9) : .
Calcaterra V,Verduci E,Cena H,Magenes VC,Todisco CF,Tenuta E .1848 .Polycystic ovary syndrome in insulin-resistant adolescents with obesity: The role of nutrition therapy and food supplements as a strategy to protect fertility. Nutrients, 10(6) : .
Smet ME,McLennan A .2018 .Rotterdam criteria, the end. Australas J Ultrasound Med, 10(2) : 59-60.
Dey R,Mukherjee S,Roybiswas R,Mukhopadhyay A,Biswas SC .2011 .Association of metabolic syndrome in polycystic ovarian syndrome: an observational study. J Obstet Gynaecol India, 10(2) : 176-181.
Goverde AJ,van Koert AJ,Eijkemans MJ,Knauff EA,Westerveld HE,Fauser BC .2009 .Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod, 10(3) : 710-717.
Bhagat A,Malhotra AS,Kaur G,Kapoor N. .2017 .Metabolic syndrome: not even the urban Indian youth is spared. Indian J Physiol Pharmacol, 61(4) : 368-77.
Eckel RH,Grundy SM,Zimmet PZ .2005 .The metabolic syndrome. Lancet, 6736(05) : 66378-7.
Shroff R,Syrop CH,Davis W,Van Voorhis BJ,Dokras A .2007 .Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril, 01(5) : 1389-1395.
Hahn S,Tan S,Sack S,Kimming R,Quadbeck B,Mann K .2007 .Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes, 10(2) : 130-135.
Janssen I,Katzmarzyk PT,Ross R .2004 .Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr, 10(3) : 379-384.
Anjum S,Askari S,Riaz M,Basit A. .2020 .Clinical presentation and frequency of metabolic syndrome in women with polycystic ovary syndrome: An experience from a tertiary care hospital in Pakistan. , 10(12) : .
Alzeidan R,Fayed A,Hersi AS,Elmorshedy H .2019 .Performance of neck circumference to predict obesity and metabolic syndrome among adult Saudis: a cross-sectional study. BMC Obes, 10 : 13.
Ren H,Guo Y,Wang D,Kang X,Yuan G .2023 .Association of normal-weight central obesity with hypertension: a cross-sectional study from the China health and nutrition survey. BMC Cardiovasc Disord, 10(1) : 120.
0

Citations

0

Downloads

100

Views